Hsbc Holdings PLC Dexcom Inc Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Dexcom Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 1,144,798 shares of DXCM stock, worth $86.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,144,798

Previous 1,269,010 9.79%

Holding current value

$86.9 Million

Previous $144 Million 46.68%

% of portfolio

0.05%

Previous 0.09%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $7.95 Million - $14.4 Million	-124,212 Reduced 9.79%	1,144,798 $76.7 Million
Q2 2024 Aug 12, 2024	BUY	$110.31 - $140.45 $27.9 Million - $35.5 Million	252,824 Added 24.88%	1,269,010 $144 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $8.68 Million - $10.6 Million	76,007 Added 8.08%	1,016,186 $141 Million
Q4 2023 Feb 12, 2024	BUY	$75.49 - $124.16 $1.58 Million - $2.59 Million	20,889 Added 2.27%	940,179 $117 Million
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $7.37 Million - $11.8 Million	-85,614 Reduced 8.52%	919,290 $85.8 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $57.3 Million - $66.8 Million	509,766 Added 102.95%	1,004,904 $129 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $4.39 Million - $5.19 Million	-42,217 Reduced 7.86%	495,138 $57.5 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $15 Million - $21.7 Million	176,974 Added 49.11%	537,355 $60.9 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $1.46 Million - $1.8 Million	-19,143 Reduced 5.04%	360,381 $29.4 Million
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $20 Million - $39.2 Million	294,835 Added 348.14%	379,524 $28.5 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $448,385 - $620,533	-4,766 Reduced 5.33%	84,689 $43.6 Million
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $641,427 - $804,167	4,939 Added 5.84%	89,455 $12 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $447,221 - $600,067	4,191 Added 5.22%	84,516 $46.2 Million
Q2 2021 Aug 13, 2021	SELL	$80.99 - $107.93 $677,076 - $902,294	-8,360 Reduced 9.43%	80,325 $8.57 Million
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $340,092 - $420,112	4,011 Added 4.74%	88,685 $7.97 Million
Q4 2020 Feb 25, 2021	SELL	$78.0 - $104.5 $78,000 - $104,500	-1,000 Reduced 1.17%	84,674 $7.83 Million
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $1.37 Million - $1.83 Million	17,533 Added 25.73%	85,674 $7.92 Million
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $97,897 - $115,773	1,025 Added 1.53%	68,141 $27.9 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $2.49 Million - $4.18 Million	39,717 Added 144.96%	67,116 $27.2 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $401,866 - $635,972	-8,409 Reduced 23.48%	27,399 $7.43 Million
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $24,169 - $37,811	-660 Reduced 1.81%	35,808 $7.82 Million
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $31,195 - $38,456	-878 Reduced 2.35%	36,468 $5.44 Million
Q2 2019 Aug 13, 2019	BUY	$27.84 - $38.92 $470,468 - $657,709	16,899 Added 82.65%	37,346 $5.6 Million
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $195,563 - $266,000	6,967 Added 51.68%	20,447 $2.44 Million
Q4 2018 Feb 13, 2019	SELL	$26.99 - $37.37 $505,306 - $699,641	-18,722 Reduced 58.14%	13,480 $1.61 Million
Q3 2018 Nov 13, 2018	BUY	$23.35 - $36.72 $259,185 - $407,592	11,100 Added 52.6%	32,202 $4.61 Million
Q2 2018 Aug 10, 2018	BUY	$17.54 - $25.22 $312,422 - $449,218	17,812 Added 541.4%	21,102 $2 Million
Q1 2018 May 11, 2018	SELL	$13.06 - $18.54 $33,080 - $46,961	-2,533 Reduced 43.5%	3,290 $244,000
Q4 2017 Feb 14, 2018	SELL	$11.12 - $15.38 $3,791 - $5,244	-341 Reduced 5.53%	5,823 $334,000
Q3 2017 Nov 14, 2017	SELL	$11.36 - $18.98 $8,985 - $15,013	-791 Reduced 11.37%	6,164 $301,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,955	6,955 $509,000

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Dexcom Inc Transaction History